Stock Taper
BSX
BOSTON SCIENTIFIC CORPORATION
NYSE
$46.84
▲ UP 0.36% (0.17)

KEY STATISTICS

Market Cap$69.62 B
52w High$109.50
52w Low$42.20
Dividend Yield
Frequency
P/E15.11
Volume17.14M
Shares Out.1.49B

COMPANY

LEADERSHIP

Michael F. Mahoney
CHIEF EXECUTIVE
Michael F. Mahoney

COMPENSATION 2026

Salary$1,442,603
Stock Awards$13,608,056
Incentive Plan Pay$4,002,001
All Other Comp.$729,410
Total$23,532,050

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 19, 1992
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
59,000

PRICE TARGET

Target High$100.00
Target Low$50.00
Target Median$63.50
Target Consensus$66.50

UPCOMING EARNINGS

DateOct 28, 2026
DayWednesday
Rev. Est.$5.26B
OCT
28
WED

SPLIT RECORD

DATETYPERATIO
2003-11-06Forward2:1
1998-12-01Forward2:1

PRICE

$46.84 ▲ UP 0.36% (+$0.17)
OVERLAYS
$46.60$46.80$47.00$47.209:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM46.84

About Boston Scientific Corporation

https://www.bostonscientific.com ↗

Boston Scientific develops and markets global medical devices across interventional specialties, including cardiovascular, neuro, and surgical solutions for diagnosing and treating various conditions.

INDUSTRY

Medical - Devices

A PRODUCT BOSTON SCIENTIFIC CORPORATION IS KNOWN FOR

FARAPULSE Pulsed Field Ablation System
FARAPULSE Pulsed Field Ablation System

The FARAPULSE PFA System by Boston Scientific, FDA-approved in 2024, is a non-thermal electric field device that safely treats atrial fibrillation, representing a transformative advancement in cardiac ablation technology.

COMPETITORS

Revenue by Products

IconPRODUCTQ2-2025Q3-2025Q4-2025Q2-2026
Cardiovascular$3.35B $3.34B $3.49B $3.62B
MedSurg$1.72B $1.72B $1.81B $1.82B

Revenue by Geography

MapREGIONQ2-2025Q3-2025Q4-2025Q2-2026
NonUS$1.84B $1.77B $1.9B $2.02B
UNITED STATES$2.04B $2.09B $5.77B $606M

RATINGS SNAPSHOT

Overall rating: A-

DCFROEROAD/EP/EP/B
Discounted Cash Flow5
Return On Equity4
Return On Assets5
Debt To Equity2
Price To Earnings2
Price To Book3
Overall Score4

TRADES BY CONGRESS

HOUSE TRADES
Ro Khanna
Ro Khanna
Sale
2026-07-07
Gilbert Cisneros
Gilbert Cisneros
Sale
2026-06-05
SENATE TRADES
John Boozman
John Boozman
Sale
2026-06-04
HOUSE TRADES
Michael McCaul
Michael McCaul
Purchase
2026-03-27

INSIDER TRADES

DIRECTOR
Morano Susan E
Purchase · 2.0K shares
2026-08-25
OFFICER: SVP, GLOBAL CONTROLLER AND CAO
Woodworth Emily
Purchase · 2.9K shares
2026-08-11
OFFICER: EVP AND CFO
Monson Jonathan
Purchase · 9.9K shares
2026-08-10
DIRECTOR
Habiger David C
Purchase · 2.1K shares
2026-08-05

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 11
OUTPERFORM 7
OVERWEIGHT 3
HOLD 1
EQUAL WEIGHT 1
PEER PERFORM 1
24 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
AMGN$432.42COMPARE
ABT$112.47COMPARE
GILD$145.68COMPARE
PFE$27.96COMPARE
DHR$216.07COMPARE
SYK$330.69COMPARE
MDT$91.23COMPARE
SNY$44.82COMPARE